Regulus Therapeutics Inc.
MicroRNA Compounds and Methods for Modulating MIR-10B Activity
Last updated:
Abstract:
Described herein are compositions and methods for the inhibition of miR-10b activity. The compositions may be administered to subjects with cancer, such as glioma.
Status:
Application
Type:
Utility
Filling date:
12 Nov 2019
Issue date:
31 Mar 2022